Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706 · see citing works

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study

Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541 · see citing works

Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies

Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · see citing works

National Cholesterol Education Program

Lenfant, C. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400060019005 · Cited by 1,184 · see citing works

Non–HDL Cholesterol, Apolipoproteins A-I and B ₁₀₀ , Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

Ridker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744 · see citing works

Triglyceride Concentration and Ischemic Heart Disease

Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 673 · see citing works

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Cui, Y. A., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., LANGENBERG, P. W., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 657 · see citing works

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women

Ingelsson, E., Schaefer, E. J., Contois, J. H., McNamara, J. R., Sullivan, L., Keyes, M. J., Pencina, M. J., Schoonmaker, C., Wilson, P. W. F., D’Agostino, R. B., et al. (2007) · JAMA · doi:10.1001/jama.298.7.776 · Cited by 608 · see citing works

Familial lipoprotein disorders in patients with premature coronary artery disease.

Genest, J. J., Martin-Munley, S., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 598 · see citing works

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men

Pischon, T., Girman, C. J., Sacks, F. M., Rifai, N., Stampfer, M. J., & Rimm, E. B. (2005) · Circulation · doi:10.1161/circulationaha.104.532499 · Cited by 514 · see citing works

Atherogenic Lipoprotein Particles in Atherosclerosis

Carmena, R., Duriez, P., & Fruchart, J.-C. (2004) · Circulation · doi:10.1161/01.cir.0000131511.50734.44 · Cited by 494 · see citing works

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. D., Durrington, P. N., Færgeman, O., Frohlich, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 463 · see citing works

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385 · see citing works

Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study

Shahar, E., Chambless, L. E., Rosamond, W. D., Boland, L. L., Ballantyne, C. M., McGovern, P. G., & Sharrett, A. R. (2003) · Stroke · doi:10.1161/01.str.0000057812.51734.ff · Cited by 325 · see citing works

Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells

Kawakami, A., Aikawa, M., Alcaide, P., Luscinskas, F. W., Libby, P., & Sacks, F. M. (2006) · Circulation · doi:10.1161/circulationaha.106.622514 · Cited by 305 · see citing works

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

McNamara, J. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278 · see citing works

Change in LDL particle size is associated with change in plasma triglyceride concentration.

McNamara, J. R., Jenner, J. L., Li, Z., Wilson, P. W., & Schaefer, E. J. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1284 · Cited by 275 · see citing works

Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations

Davidson, M. H., Maki, K. C., Pearson, T. A., Pasternak, R. C., Deedwania, P. C., McKenney, J. M., Fonarow, G. C., Maron, D. J., Ansell, B. J., Clark, L. T., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.019 · Cited by 270 · see citing works

New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism

Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255 · see citing works

Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women

Shai, I., Rimm, E. B., Hankinson, S. E., Curhan, G. C., Manson, J. E., Rifai, N., Stampfer, M. J., & Ma, J. (2004) · Circulation · doi:10.1161/01.cir.0000146339.57154.9b · Cited by 235 · see citing works

Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis

Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00001 · Cited by 200 · see citing works

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study

Miller, M., Seidler, A., Moalemi, A., & Pearson, T. A. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00083-7 · Cited by 193 · see citing works

Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.

Chapman, M. J., Guérin, M., & Bruckert, É. (1998) · PubMed · Cited by 178 · see citing works

Low Triglycerides–High High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease

Jeppesen, J., Hein, H. O., Suadicani, P., & Gyntelberg, F. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.361 · Cited by 175 · see citing works

Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI)

Bittner, V., Hardison, R., Kelsey, S. F., Weiner, B. H., Jacobs, A. K., & Sopko, G. (2002) · Circulation · doi:10.1161/01.cir.0000038496.57570.06 · Cited by 168 · see citing works

Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease

Brewer, H. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00308-2 · Cited by 157 · see citing works

Triglyceride-Rich Lipoproteins Prime Aortic Endothelium for an Enhanced Inflammatory Response to Tumor Necrosis Factor-α

Ting, H. J., Stice, J. P., Schaff, U. Y., Hui, D. Y., Rutledge, J. C., Knowlton, A. A., Passerini, A. G., & Simon, S. I. (2007) · Circulation Research · doi:10.1161/01.res.0000258023.76515.a3 · Cited by 138 · see citing works

Elevated Remnant-Like Particle Cholesterol and Triglyceride Levels in Diabetic Men and Women in the Framingham Offspring Study

Schaefer, E. J., McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Ordovás, J. M., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.989 · Cited by 134 · see citing works

Low density lipoprotein size, pravastatin treatment, and coronary events.

Campos, H. (2001) · JAMA · doi:10.1001/jama.286.12.1468 · Cited by 132 · see citing works

Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses.

Campos, H., Dreon, D. M., & Krauss, R. M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39880-1 · Cited by 121 · see citing works

Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II

Ballantyne, C. M., Bertolami, M. C., García, H. R. H., Nul, D. R., Stein, E. A., Théroux, P., Weiss, R., Cain, V. A., & Raichlen, J. S. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.12.013 · Cited by 112 · see citing works

Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100

ABATEA, N., Vega, G., & Grundy, S. M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90187-y · Cited by 76 · see citing works

The apolipoprotein story

Sacks, F. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.05.004 · Cited by 75 · see citing works

Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.

Goldberg, I. J., Le, N., Ginsberg, H. N., Krauss, R. M., & Lindgren, F. T. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113354 · Cited by 74 · see citing works

Combination Therapy with Statins and Omega-3 Fatty Acids

Nambi, V., & Ballantyne, C. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.025 · Cited by 62 · see citing works

Non–High-Density Lipoprotein Cholesterol: The Forgotten Therapeutic Target

Maki, K. C., Galant, R., & Davidson, M. H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.009 · Cited by 28 · see citing works

The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy

Wiviott, S. D., & Cannon, C. P. (2006) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328010872d · Cited by 27 · see citing works

Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association

Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works

Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease

Waterworth, D. M., Ricketts, S. L., Song, K., Chen, L., Zhao, J. H., Ripatti, S., Aulchenko, Y. S., Zhang, W., Yuan, X., Lim, N., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201020 · Cited by 405 · see citing works

The Role of Triglycerides in Atherosclerosis

Talayero, B., & Sacks, F. M. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0220-3 · Cited by 356 · see citing works

Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices

Contois, J. H., McConnell, J. P., Sethi, A. A., Csako, G., Devaraj, S., Hoefner, D. M., & Warnick, G. R. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.118356 · Cited by 326 · see citing works

Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications

Bays, H., Tighe, A., Sadovsky, R., & Davidson, M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.391 · Cited by 271 · see citing works

A modified formula for calculating low-density lipoprotein cholesterol values

Chen, Y., Zhang, X., Pan, B., Jin, X., Yao, H., Chen, B., Zou, Y., Ge, J., & Chen, H. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-52 · Cited by 229 · see citing works

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis

Liao, K. P., Playford, M. P., Frits, M. L., Coblyn, J. S., Iannaccone, C. K., Weinblatt, M. E., Shadick, N. A., & Mehta, N. N. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001588 · Cited by 145 · see citing works

Non-HDL-cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population

van Deventer, H. E., Miller, W. G., Myers, G. L., Sakurabayashi, I., Bachmann, L. M., Caudill, S. P., Dziekonski, A., Edwards, S., Kimberly, M. M., Korzun, W. J., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.154773 · Cited by 112 · see citing works

Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis

Gjuladin-Hellon, T., Davies, I. G., Penson, P., & Amiri Baghbadorani, R. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuy049 · Cited by 108 · see citing works

Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease

Shibabaw, T. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03965-7 · Cited by 108 · see citing works

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., & Keech, A. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1806-9 · Cited by 94 · see citing works

Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use

Mora, S. (2009) · Circulation · doi:10.1161/circulationaha.108.819359 · Cited by 89 · see citing works

TM6SF2 G lu167 L ys polymorphism is associated with low levels of LDL ‐cholesterol and increased liver injury in obese children

Grandone, A., Cozzolino, D., Marzuillo, P., Cirillo, G., Sessa, A. D., Ruggiero, L., Palma, M. R. D., Perrone, L., & del Giudice, E. M. (2015) · Pediatric Obesity · doi:10.1111/ijpo.12032 · Cited by 86 · see citing works

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children

D’Adamo, E., Guardamagna, O., Chiarelli, F., Bartuli, A., Liccardo, D., Ferrari, F., & Nobili, V. (2015) · International Journal of Endocrinology · doi:10.1155/2015/912047 · Cited by 83 · see citing works

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.040 · Cited by 83 · see citing works

Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes

FinnDiane Study Group, Tolonen, N., Forsblom, C. M., Thorn, L. M., Wadén, J., Rosengård‐Bärlund, M., Saraheimo, M., Feodoroff, M., Mäkinen, V., Gordin, D., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1541-2 · Cited by 77 · see citing works

Effectiveness of Combined Statin Plus Omega-3 Fatty Acid Therapy for Mixed Dyslipidemia

Barter, P. J., & Ginsberg, H. N. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.056 · Cited by 72 · see citing works

Estimation of Plasma Small Dense LDL Cholesterol From Classic Lipid Measures

Srisawasdi, P., Chaloeysup, S., Teerajetgul, Y., Pocathikorn, A., Sukasem, C., Vanavanan, S., & Kroll, M. H. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcplhjbgg9l3ils · Cited by 66 · see citing works

Non-HDL Cholesterol Levels in Childhood and Carotid Intima-Media Thickness in Adulthood

Juonala, M., Wu, F., Sinaiko, A. R., Woo, J. G., Urbina, E. M., Jacobs, D. R., Steinberger, J., Prineas, R. J., Koskinen, J. M., Sabin, M. A., et al. (2020) · PEDIATRICS · doi:10.1542/peds.2019-2114 · Cited by 63 · see citing works

Untreated HIV Infection and Large and Small Artery Elasticity

Baker, J. V., Duprez, D. A., Rapkin, J. S., Hullsiek, K. H., Quick, H. S., Grimm, R. H., Neaton, J. D., & Henry, K. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b02e6a · Cited by 62 · see citing works

Non−High-Density Lipoprotein Cholesterol: Distribution and Prevalence of High Serum Levels in Children and Adolescents: United States National Health and Nutrition Examination Surveys, 2005-2010

Dai, S., Yang, Q., Yuan, K., Loustalot, F. V., Fang, J., Daniels, S. R., & Hong, Y. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.08.069 · Cited by 61 · see citing works

Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults

Björnsson, E., Þorleifsson, G., Helgadóttir, A., Guðnason, Þ., Guðbjartsson, T., Andersen, K. K., Grétarsdóttir, S., Ólafsson, Í., Tragante, V., Ólafsson, Ó., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2946 · Cited by 59 · see citing works

Low serum high‐density lipoprotein cholesterol in childhood is associated with adolescent asthma

Yiallouros, P. K., Savva, S. C., Kolokotroni, O., Behbod, B., Zeniou, M., Economou, M., Chadjigeorgiou, C., Kourides, Y. A., Tornaritis, M. J., Lamnisos, D., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03940.x · Cited by 58 · see citing works

Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment

Ponte-Negretti, C. I., Isea-Perez, J. E., Lorenzatti, A. J., López-Jaramillo, P. A., Wyss-Q, F. S., Pintó, X., Lanas, F. T., Medina, J., Machado-H, L. T., Mónica Acevedo, B., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.05.059 · Cited by 60 · see citing works

Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0047 · Cited by 52 · see citing works

Relations of lipid parameters, other variables with carotid intima-media thickness and plaque in the general Chinese adults: an observational study

Hou, Q., Li, S., Gao, Y., & Tian, H. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0758-9 · Cited by 50 · see citing works

Non‐high‐density lipoprotein cholesterol: An important predictor of stroke and diabetes‐related mortality in Japanese elderly diabetic patients

Araki, A., Iimuro, S., Sakurai, T., Umegaki, H., Iijima, K., Nakano, H., Oba, K., Yokono, K., Sone, H., Yamada, N., et al. (2012) · Geriatrics &amp; Gerontology International · doi:10.1111/j.1447-0594.2011.00809.x · Cited by 49 · see citing works

Dietary Docosahexaenoic Acid and Eicosapentaenoic Acid Influence Liver Triacylglycerol and Insulin Resistance in Rats Fed a High-Fructose Diet

de Castro, G. S., Deminice, R., Simões-Ambrósio, L. M. C., Calder, P. C., Jordão, A. A., & Vannucchi, H. (2015) · Marine Drugs · doi:10.3390/md13041864 · Cited by 49 · see citing works

Are You Targeting Non–High-Density Lipoprotein Cholesterol?

Robinson, J. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.056 · Cited by 44 · see citing works

Fibrates: no ACCORD on their use in the treatment of dyslipidaemia

Wierzbicki, A. S. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833c1e74 · Cited by 39 · see citing works

Usefulness of lipid ratios and atherogenic index of plasma in obese Moroccan women with or without metabolic syndrome.

Essiarab, F., Taki, H., Lebrazi, H., Sabri, M., & Saı̈le, R. (2014) · PubMed · Cited by 38 · see citing works

Lipid-altering effects of a dietary supplement tablet containing free plant sterols and stanols in men and women with primary hypercholesterolaemia: a randomized, placebo-controlled crossover trial

Maki, K. C., Lawless, A. L., Reeves, M. S., Dicklin, M. R., Jenks, B. H., Shneyvas, E., & Brooks, J. R. (2011) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2011.636345 · Cited by 37 · see citing works

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0380 · Cited by 34 · see citing works

Non-traditional Lipid Parameters as Potential Predictors of Asymptomatic Intracranial Arterial Stenosis

Guo, J., Wang, A., Wang, Y., Liu, X., Zhang, X., Wu, S., & Zhao, X. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.679415 · Cited by 35 · see citing works

The role of triglycerides in cardiovascular risk

Gandotra, P., & Miller, M. J. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0079-0 · Cited by 32 · see citing works

Effects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China

Chi, X., Zhang, T., Zhang, D., Yu, W., Wang, Q., & Zhen, J.-L. (2016) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-147 · Cited by 32 · see citing works

Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia

Wierzbicki, A. S. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32832c0b3d · Cited by 31 · see citing works

Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol

Liting, P., Lü, G., & Zhenyue, C. (2014) · Herz · doi:10.1007/s00059-014-4147-5 · Cited by 30 · see citing works

Nibbling versus feasting: which meal pattern is better for heart disease prevention?

Bhutani, S., & Varady, K. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00231.x · Cited by 29 · see citing works

Reference Ranges for the Non-High-Density Lipoprotein Cholesterol Levels in Japanese Children and Adolescents

Abe, Y., Okada, T., スギウラ, レ., Yamauchi, K., & Murata, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.28100 · Cited by 29 · see citing works

Lipid-lowering effect of cordycepin (3'-deoxyadenosine) from Cordyceps militaris on hyperlipidemic hamsters and rats.

Gao, J. H., Lian, Z., Zhu, P., & Zhu, H. (2011) · PubMed · Cited by 27 · see citing works

Comparison of remnant cholesterol levels estimated by calculated and measured LDL-C levels in Chinese patients with coronary heart disease

Xiang, Q., Tian, F., Lin, Q., Du, X., Zhang, S., Gui, Y., Guo, L., Xu, J. R., Zhu, L., Wen, T., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.020 · Cited by 26 · see citing works

A Risk-Stratification Machine Learning Framework for the Prediction of Coronary Artery Disease Severity: Insights From the GESS Trial

Mittas, N., Chatzopoulou, F. M., Kyritsis, K., Papagiannopoulos, C. I., Theodoroula, N. F., Papazoglou, Α. S., Karagiannidis, E., Sofidis, G., Moysidis, D. V., Stalikas, N., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.812182 · Cited by 26 · see citing works

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease

Maki, K. C., Davidson, M. H., Dicklin, M. R., Bell, M., Witchger, M., & Feinstein, S. B. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.003 · Cited by 26 · see citing works

There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5

Chiu, H., Wu, P.-Y., Huang, J.-C., Tu, H., Lin, M.-Y., Chen, S.-C., & Chang, J.-M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69794-2 · Cited by 26 · see citing works

Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations

Lütjohann, D., Klör, H., & Stellaard, F. (2023) · Nutrients · doi:10.3390/nu15092202 · Cited by 25 · see citing works

MARCH2: Comparative Assessment of Therapeutic Effects of Acarbose and Metformin in Newly Diagnosed Type 2 Diabetes Patients

Wang, G., Liu, J., Yang, N., Gao, X., Fan, H. J., Xu, Y., & Yang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105698 · Cited by 23 · see citing works

Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review

Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427092114 · Cited by 21 · see citing works

Serum Triglyceride Levels Independently Contribute to the Estimation of Visceral Fat Amount Among Nondiabetic Obese Adults

Huang, C., Huang, H., Yang, K., Lee, L., Yang, W., Huang, K., & Tseng, F. (2015) · Medicine · doi:10.1097/md.0000000000000965 · Cited by 21 · see citing works

Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China

Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y.-K., Yang, J., & Zhou, Y.-J. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01355-y · Cited by 20 · see citing works

Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy

Masana, L., Ibarretxe, D., Heras, M., Cabré, A., Ferré, R., Merino, J., Plana, N., & Girona, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.001 · Cited by 19 · see citing works

Characterization of Portuguese Centenarian Eating Habits, Nutritional Biomarkers, and Cardiovascular Risk: A Case Control Study

da Silva, A. P., Valente, A., Chaves, C., Matos, A., Gil, Á., Santos, A. C., Gorjão-Clara, J. P., & Bicho, M. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5296168 · Cited by 19 · see citing works

Omega-3 fatty acids for the treatment of elevated triglycerides

Maki, K. C., Dicklin, M. R., Lawless, A. L., & Reeves, M. P. (2009) · Clinical Lipidology · doi:10.2217/clp.09.34 · Cited by 18 · see citing works

Evaluation of Established Coronary Heart Disease on the Basis of HDL and Non-HDL NMR Lipid Profiling

Kostara, C. E., Papathanasiou, A. I., Cung, M. T., Elisaf, M., Goudevenos, J. A., & Bairaktari, E. T. (2009) · Journal of Proteome Research · doi:10.1021/pr900783x · Cited by 18 · see citing works

Is measurement of non-HDL cholesterol an effective way to identify the metabolic syndrome?

Liu, A., & Reaven, G. M. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.12.001 · Cited by 17 · see citing works

A randomized study of dietary composition during weight-loss maintenance: Rationale, study design, intervention, and assessment

Ebbeling, C. B., Klein, G. L., Luoto, P. K., Wong, J. M., Bielak, L., Eddy, R. G., Steltz, S. K., Devlin, C. A., Sandman, M., Hron, B. M., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.12.004 · Cited by 17 · see citing works

Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial

Faghihi, T., Jahed, S. A., Mahmoudi‐Gharaei, J., Sharifi‎, V., Akhondzadeh, S., & Ghaeli, P. (2012) · DARU Journal of Pharmaceutical Sciences · doi:10.1186/2008-2231-20-43 · Cited by 16 · see citing works

JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models

Mera, Y., Kawai, T., Ogawa, N., Odani, N., Sasase, T., Miyajima, K., Ohta, T., & Kakutani, M. (2015) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2015.10.004 · Cited by 14 · see citing works

Hypertriglyceridaemia, Postprandial Lipaemia and Non-HDL Cholesterol

Stefanutti, C., Labbadia, G., & Athyros, V. G. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140620120130 · Cited by 13 · see citing works

Effect of High-Intensity Strength and Endurance Training in the Form of Small Circuits on Changes in Lipid Levels in Men Aged 35–40 Years

Ambroży, T., Rydzik, Ł., Obmiński, Z., Spieszny, M., Szczepanik, A., Ambroży, D., Basiaga-Pasternak, J., Spieszny, J., Niewczas, M., & Jaszczur-Nowicki, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175146 · Cited by 12 · see citing works

Carotid intima-media and epicardial adipose tissue thickness in adult patients with epilepsy taking anti-seizure medication and its long-term significance

Lima, B. S., Mohamadzadeh, A., Dadras, M., Mahdavi, A., Mansouri, B., & Farazdaghi, M. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108432 · Cited by 12 · see citing works

Managing Mixed Dyslipidemia in Special Populations

Miller, M. J. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2009.00057.x · Cited by 10 · see citing works

Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol

Toth, P. P., Zarotsky, V., Sullivan, J. M., & Laitinen, D. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990902910450 · Cited by 10 · see citing works

Distribution and correlates of non–high-density lipoprotein cholesterol and triglycerides in Lebanese school children

Gannagé‐Yared, M., Farah, V., Chahine, E., Balech, N., Ibrahim, T., Asmar, N., Barakett, V., & Jambart, S. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.12.018 · Cited by 10 · see citing works

Genome-wide association studies identified novel loci for non-high-density lipoprotein cholesterol and its postprandial lipemic response

An, P., Straka, R. J., Pollin, T. I., Feitosa, M. F., Wojczynski, M. K., Daw, E. W., O’Connell, J. R., Gibson, Q., Ryan, K. A., Hopkins, P. N., et al. (2014) · Human Genetics · doi:10.1007/s00439-014-1435-3 · Cited by 9 · see citing works

Biochemical Markers of Atherosclerosis

Đerić, M., Kojić-Damjanov, S., Čabarkapa, V., & Eremić, N. (2008) · Journal of Medical Biochemistry · doi:10.2478/v10011-008-0008-1 · Cited by 9 · see citing works

Non-high-density Lipoprotein Cholesterol Levels in Japanese Obese Boys with Metabolic Syndrome

Saito, E., Okada, T., Abe, Y., Kazama, M., Yonezawa, R., Kuromori, Y., Iwata, F., & Hara, M. (2015) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.30692 · Cited by 8 · see citing works

Limitations of current screening methods for lipid disorders in Korean adolescents and a proposal for an effective detection method: a nationwide, cross-sectional study

Shin, J. H., Cheong, J. I., Cheuh, H. W., & Yoo, J. H. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040098.049 · Cited by 7 · see citing works

Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study

Khan, S., Kumar, Y., Sharma, C., Gupta, S. K., Goel, A., Aggarwal, R., & Veerapu, N. S. (2023) · Journal of Viral Hepatitis · doi:10.1111/jvh.13885 · Cited by 7 · see citing works

Assessment of Cardiovascular Risk indices in Type 2 Diabetes Mellitus

Adu, M. E. (2015) · Tropical Medicine & Surgery · doi:10.4172/2329-9088.1000184 · Cited by 7 · see citing works

Analysis of the Correlation between Non-high Density Lipoprotein Cholesterol and Coronary Heart Disease in Elderly Chinese

Ke, D., Chen, Q., Wu, Q. F., Li, X., Wu, Z., Li, G., Deng, W., & Mo, X. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.4988 · Cited by 6 · see citing works

Lack of Association between High-Density Lipoprotein Cholesterol and Angiographic Coronary Lesion Severity in Chinese Patients with Low Background Low-Density Lipoprotein Cholesterol.

Su, C., Chen, K. J., Sheu, W. H., Yang, Y. L., Liu, T.-J., Chang, W. C., Wang, K. Y., & Lee, W.-L. (2015) · Europe PMC (PubMed Central) · doi:10.6515/acs20150421a · Cited by 6 · see citing works

Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan

Yokomichi, H., Noda, H., Nagai, A., Hirata, M., Tamakoshi, A., Kamatani, Y., Kiyohara, Y., Matsuda, K., Muto, K., Ninomiya, T., et al. (2017) · Journal of Epidemiology · doi:10.1016/j.je.2016.12.014 · Cited by 6 · see citing works

Triglycerides and Cardiovascular Disease : A Scientific Statement From the

Pennathur, S., Kris‐Etherton, P. M., Lennie, T. A., Levi, M., Mazzone, T., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Stone, N. J., Ballantyne, C. M., et al. (2011) · Cited by 6 · see citing works

Impact on Longevity of Genetic Cardiovascular Risk and Lifestyle including Red Meat Consumption

da Silva, A. P., Costa, M. D. C., Aguiar, L., Matos, A., Gil, Â., Clara, J. G., Polónia, J. J., & Bicho, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1305413 · Cited by 6 · see citing works

Association of the “life’s crucial 9” cardiovascular health with all-cause and cardiovascular disease mortality: a national cohort study

Tu, D., Xu, Q., Sun, J., Li, P., & Ma, C. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01607-2 · Cited by 5 · see citing works

Associations between anthropometric parameters and serum lipids in preadolescent and adolescent girls and boys

Ninić, A., Spasojević‐Kalimanovska, V., Bogavac‐Stanojević, N., Kotur‐Stevuljević, J., Kornic-Ristovski, D., Stefanović, A., Spasić, S., Deanović, M., Babka, S., Aleksic, B., et al. (2015) · Clinical Lipidology · doi:10.2217/clp.15.2 · Cited by 5 · see citing works

Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients

Farnier, M., Taggart, W. V., Dong, Q., Lin, J., Shah, A. K., & Brudi, P. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.02.009 · Cited by 5 · see citing works

Using omega-3 fatty acids in the practice of clinical lipidology

Brown, W. V., Bays, H. E., Harris, W. S., & Miller, M. J. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.09.006 · Cited by 4 · see citing works

Cardio-Ankle Vascular Index and C-Reactive Protein Are Useful Parameters for Identification of Ischemic Heart Disease in Acute Heart Failure Patients

Kiuchi, S., Hisatake, S., Kabuki, T., Oka, T., Dobashi, S., Fujii, T., & Ikeda, T. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2994w · Cited by 4 · see citing works

Non-High-Density Lipoproteins Cholesterol and Cardio-Metabolic Risk.

Bâibâță, D. E., Ionescu, G., Petcov, B., & Mancaş, S. (2015) · Europe PMC (PubMed Central) · Cited by 3 · see citing works

Efficacy of Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High-Risk Patients With or Without Obesity

Missault, L. H., Averna, M. R., Farnier, M., Vaverková, H., Viigimaa, M., Dong, Q., Shah, A. K., Johnson‐Levonas, A. O., Taggart, W. V., & Brudi, P. (2011) · Combination Products in Therapy · doi:10.1007/s13556-011-0001-8 · Cited by 3 · see citing works

Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study

Torii, H., Shimizu, R., 谷崎百合子, Omiya, Y., Yamamoto, M., Kamiike, S., Yasuda, D., Hiraoka, Y., Hashida, T., & Kume, N. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00411 · Cited by 3 · see citing works

Quel bilan lipidique et comment l’interpréter chez le patient ayant une maladie coronaire ?

Farnier, M. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.03.004 · Cited by 3 · see citing works

Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee

Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3 · see citing works

Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome

Yun, K. H., Shin, I.-S., Rhee, S. J., Lee, E. M., Yoo, N. J., Kim, N., Oh, S. K., & Jeong, J. W. (2009) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2009.24.4.330 · Cited by 2 · see citing works

LIPID EXCHANGE INDEXES: INFORMATION CAPACITY AND CLINICAL MEANING IN THE COURSE OF VALUATION OF ATHEROGENICITY OF LIPEMIC INDEX OF BLOOD

Kaneva, A. M., & Bojko, E. R. (2017) · Medical academic journal · doi:10.17816/maj17141-50 · Cited by 2 · see citing works

Asprosin in early detection of nephropathy in type2 diabetes mellitus

Alwahid, O. H. A., Khalil, T. T., & Ismael, M. A. A.-R. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_43_23 · Cited by 1 · see citing works

Translation: Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population

van Deventer, H. E., Miller, W. G., Myers, G. L., Sakurabayashi, I., Bachmann, L. M., Caudill, S. P., Dziekoński, A., Edwards, S. H., Kimberly, M. M., Korzun, W. J., et al. (2011) · Laboratory Medicine Online · doi:10.3343/lmo.2011.1.3.1 · Cited by 1 · see citing works

Integrative Treatments to Reduce Risk for Cardiovascular Disease.

Bradley, R. D., & Oberg, E. B. (2009) · PubMed · Cited by 1 · see citing works

Study on Atherosclerotic Dyslipidemia Using Cardiovascular Risk Prediction Index

An, H. J. (2024) · Bangsaseon gisul gwahak/Journal of radiological science and technology · doi:10.17946/jrst.2024.47.5.325 · Cited by 1 · see citing works

Estatinas y factor de necrosis tumoral alfa

Obregón, O., Aure, G., Lares, M., Castro, J., Stulin, I., Rivas, K., Aponte, A., Martínez, J. A. B., & Martínez, O. M. (2010) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1 · see citing works

Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care

van der Heyden, J. C., Birnie, E., Bovenberg, S. A., Dekker, P., Veeze, H. J., Mul, D., & Aanstoot, H. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0950-9677 · Cited by 1 · see citing works

Current Concepts in Management of Lipid Abnormalities in Patients With Coronary Artery Disease

Mahajan, K., & Chandra, K. S. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620943020 · Cited by 1 · see citing works

The effects of triglyceride on lysosomal function in macrophage foam cells.

Ullery, J. C. (2009) · Europe PMC (PubMed Central) · Cited by 1 · see citing works

Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol

Ito, M. K., McKenney, J. M., & Brinton, E. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s1-c.1

Triglycerides and Cardiovascular Disease: A Scientific Statement From the American

Lennie, T. A., Levi, M., Mazzone, T., Pennathur, S., Goldberg, A. C., Howard, W. J., Jacobson, M. Z., Stone, N. J., Ballantyne, C. M., Bittner, V., et al. (2013)

Serum High Sensitivity C-Reactive Protein and Non-High Density Lipoprotein Cholesterol Levels as Cardiovascular Risk Factors in Patients with Type 2 Diabetes

Chantapet, P., Gat-ngern, P., Sawanpanyalert, P., Naulkhum, P., & Jaikua, P. (2011) · Journal of Health Research

Current World Literature

(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328329fcc2

Prognostic Impact of Remnant-like Particle Cholesterol in Patients with Differing Glucose Metabolic Status: an Observational Cohort Study from ChinaPreprint

Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y.-K., Yang, J., & Zhou, Y. (2020) · doi:10.21203/rs.3.rs-33302/v1

Role of non–high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials

Xydakis, A. M., & Ballantyne, C. M. (2003) · Current Opinion in Cardiology · doi:10.1097/00001573-200311000-00012 · Cited by 25 · see citing works

Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?

Rana, J. S., & Boekholdt, S. M. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32833f0365 · Cited by 11 · see citing works

The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease

Rana, J. S., Boekholdt, S. M., Kastelein, J. J. P., & Shah, P. K. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0224-x · Cited by 64 · see citing works

Non-HDL Cholesterol as a Measure of Atherosclerotic Risk

Packard, C. J., & Saitō, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.6 · Cited by 95 · see citing works

‘Trig-onometry’: non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia

Jacobson, T. A. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02547.x · Cited by 17 · see citing works